Options
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
Date Issued
2019
Author(s)
Albani, Diego
Marizzoni, Moira
Ferrari, Clarissa
Fusco, Federica
Boeri, Lucia
Raimondi, Ilaria
Jovicich, Jorge
Babiloni, Claudio
Soricelli, Andrea
Lizio, Roberta
Galluzzi, Samantha
Cavaliere, Libera
Didic, Mira
Schönknecht, Peter
Molinuevo, José Luis
Nobili, Flavio
Parnetti, Lucilla
Payoux, Pierre
Bocchio, Luisella
Salvatore, Marco
Rossini, Paolo Maria
Tsolaki, Magda
Visser, Pieter Jelle
Richardson, Jill C.
Bordet, Régis
Blin, Olivier
Forloni, Gianluigi
Frisoni, Giovanni B.
Editor(s)
Perry, George
DOI
10.3233/JAD-180321
